| 2024-04-11 | -1.22 % |
|
| 2024-04-09 | +2.08 % |
- The article discusses how Valley National Advisers Inc. reduced its stake in Quest Diagnostics Incorporated (DGX) by 4.1% during the fourth quarter, leading to a positive impact on DGX stock price, which rose by 2.08%. The increase in DGX stock might be attributed to various large investors buying and selling shares of the stock, influencing market sentiment with positive financial indicators such as reported earnings per share, revenue results, and a recently boosted quarterly dividend, encouraging investor confidence.
- The article discusses how Quest Diagnostics (DGX) stock was up by 2.08% last night after Leerink Partnrs lowered their Q1 2024 EPS estimates for the company, with analysts anticipating $1.84 per share for the quarter, and provides insights on various estimates and ratings for the stock, alongside recent trading and financial data; the stock likely saw an increase due to favorable quarter earnings and revenue results, exceeding consensus estimates.
|
| 2024-04-05 | -0.66 % |
|
| 2024-04-04 | -0.67 % |
|
| 2024-03-26 | -0.32 % |
|
| 2024-03-25 | -0.02 % |
|
| 2024-03-22 | +0.36 % |
|
| 2024-03-21 | +0.87 % |
- The article discusses how Naples Global Advisors LLC increased its holdings in Quest Diagnostics Incorporated (DGX) by 1.5% in the 4th quarter, leading to the stock being up 0.87%, and institutional investors like Vanguard Group Inc., American Century Companies Inc., Victory Capital Management Inc., Wellington Management Group LLP, and Geode Capital Management LLC have also adjusted their positions in the company, resulting in a positive outlook on the stock which is currently rated as a "Hold" with a consensus price target of $144.18. DGX stock rose due to increased investment and positive reports about the company's earnings and dividends, signaling a favorable performance.
- The article discusses how Ziegler Capital Management LLC lowered its stake in Quest Diagnostics Inc. (NYSE: DGX) by 3.3% in the fourth quarter, leading to an increase in the stock value by 0.87% last night. The stock went up due to various hedge funds making changes to their positions in the company, including acquisitions and increases in holdings.
- The article discusses Quest Diagnostics Incorporated (DGX) stock, which rose by 0.87% last night due to Zacks Research analysts lifting their FY2024 earnings estimates for the company, with a consensus estimate for the year being $8.75 per share, and other analysts providing positive ratings and target price increases, as well as institutional investors and company insiders making moves with the stock.
|
| 2024-03-19 | +0.72 % |
|
| 2024-03-12 | +0.24 % |
|
| 2024-03-05 | -0.64 % |
|
| 2024-03-01 | -0.17 % |
- The article discusses the Treasurer of the State of North Carolina reducing its position in Quest Diagnostics Incorporated (NYSE: DGX) by 2.1% in the 3rd quarter, leading to a -0.17% decrease in the stock last night, with several other institutional investors also adjusting their positions, and research firms providing various ratings on DGX, ultimately resulting in a consensus rating of "Hold" and an average price target of $145.92, and the stock's recent quarterly earnings results were positive, with a return on equity of 15.79% and a net margin of 9.23%, but the stock still went down due to the selling activities of large stakeholders and general market sentiment.
- Summary: Natixis Advisors L.P. decreased its stake in Quest Diagnostics and other institutional investors made changes as well; however, the stock went down by -0.17%. The stock fell due to the decrease in stake by Natixis Advisors L.P. and possible implications on overall investor sentiment.
Reason for the stock going down: The decrease in the stake held by Natixis Advisors L.P. and other institutional investors, as summarised by their recent filings with the Securities and Exchange Commission, may have impacted investor sentiment and contributed to the decline in Quest Diagnostics' stock.
- The article discusses how Stifel Financial Corp raised its stake in Quest Diagnostics Incorporated (DGX) by 6.3% and various other institutional investors bought and sold shares of the stock. Quest Diagnostics stock went down by -0.17% last night possibly due to the increase in stake by Stifel Financial Corp and other hedge fund transactions, coupled with insider selling of company stock, as well as mixed analyst ratings and the company's recent earnings results that showed a decrease in revenue compared to the same quarter last year.
|
| 2024-02-29 | -0.61 % |
|
| 2024-02-28 | -0.61 % |
|
| 2024-02-27 | +0.18 % |
|
| 2024-02-26 | -0.69 % |
- The article discusses how Quest Diagnostics (DGX) stock went down by -0.69% last night, with Zacks Research raising their earnings per share estimates for Q2 2024, and several analysts providing ratings and target prices for the stock, ultimately resulting in a consensus rating of "Hold." The stock likely went down due to various factors such as changing analyst ratings, company performance, and market conditions.
- The article discusses the recent stock activity of Quest Diagnostics Incorporated, with the stock experiencing a decrease of 0.69% due to Director Vicky B. Gregg selling 2,500 shares at an average price of $126.64, leading to market speculation and potential impact on the stock price.
- The article summarizes recent research calls in the market, highlighting upgrades and downgrades of various stocks, such as Quest Diagnostics (DGX) being initiated with a Market Perform rating, and explains that the stock went down because of these recent downgrades and reduction in price targets by analysts.
|
| 2024-02-23 | +1.39 % |
|
| 2024-02-20 | -0.16 % |
|
| 2024-02-15 | -1.56 % |
|
| 2024-02-12 | +2.58 % |
|
| 2024-02-08 | -0.69 % |
|
| 2024-02-07 | +0.92 % |
|
| 2024-02-05 | -0.98 % |
|
| 2024-02-02 | -1.71 % |
|
| 2024-02-01 | -0.98 % |
|
| 2024-01-31 | -0.31 % |
|
| 2024-01-30 | -0.39 % |
|
| 2024-01-26 | +0.22 % |
|
| 2024-01-25 | +1.87 % |
|
| 2024-01-22 | -1.4 % |
|
| 2024-01-17 | -0.1 % |
|
| 2024-01-10 | -3.53 % |
|
| 2024-01-09 | +0.36 % |
|
| 2024-01-08 | -0.27 % |
|
| 2023-12-21 | +0.94 % |
|
| 2023-12-20 | -1.23 % |
|
| 2023-12-19 | +0.46 % |
|
| 2023-12-12 | +1.8 % |
|
| 2023-12-06 | +0.02 % |
|
| 2023-12-05 | -1.89 % |
|
| 2023-11-28 | +0.3 % |
|
| 2023-11-10 | +0.9 % |
|
| 2023-11-09 | -1.37 % |
|
| 2023-11-03 | +1.96 % |
|
| 2023-11-02 | -0.91 % |
|
| 2023-10-31 | +0.53 % |
|
| 2023-10-30 | +1.35 % |
|
| 2023-10-24 | +1.75 % |
|
| 2023-10-19 | +0.03 % |
|
